Novavax Inc Company News


29 Apr, 2024 @ 12:10 by Yahoo! Finance

These stocks aren't bargains.

27 Apr, 2024 @ 18:11 by Seeking Alpha

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Catalysts lie ahead for both of these companies.

19 Apr, 2024 @ 15:02 by Yahoo! Finance

In this article, we will take a detailed look at the 12 Most Shorted Stocks in 2024. For a quick overview of such stocks, read our article 5 Most Shorted Stocks in 2024. Short-sellers may be annoying for corporations (and Redditors?), but investors usually find themselves thanking these companies for doing the often back-breaking and excruciating research that […]

15 Apr, 2024 @ 11:48 by Seeking Alpha

Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of Novavax, in a letter to the board says that the low share price reflects the board and management’s failure to capitalize on Novavax’s many significant competitive advantages and TAM opportunities The letter highlights that the underperformance is self-inflicted and is the result of reactive leadership and outd

Novavax shareholder Shah Capital is pushing the vaccine maker to add two of its nominees to the board to help tackle "underperformance" at the company and improve its share price. The hedge fund nominated Suresh Katta, founder and CEO of biotech firm Saama, and Venkat Peri, CEO of Quantiva Health, to Novavax's eight-member board, saying the duo had the experience in setting the company's strategic direction.

13 Apr, 2024 @ 20:22 by Yahoo! Finance

Who wins this face-to-face between two beaten-down biotechs?

12 Apr, 2024 @ 10:35 by Yahoo! Finance

Is there still too much risk surrounding this business?

11 Apr, 2024 @ 13:12 by Yahoo! Finance

To extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple restructuring initiatives that are aimed at lowering operating expenses and enhancing profitability.

The 2024 presidential election is shaping up to be just as exciting and contentious the 2020 contest. That’s because it looks to be a rematch between President Biden and former President Trump. There’s a wildcard thrown in this time with Robert Kennedy Jr. running an independent campaign that could pull voters from both sides. The stock market went on a rollercoaster ride four years ago. A decade-long bull market was brought up short by the pandemic. The S&P 500 lost one-third of its value in a

(Bloomberg) -- A former Phlow Corp. executive and his cousin admitted to insider trading on confidential information about a pandemic-related government loan to Eastman Kodak Co. Most Read from BloombergKim Jong Un Faces Annihilation in Most Korea War ScenariosApple Explores Home Robotics as Potential ‘Next Big Thing’ After Car FizzlesTSMC Facilities to Resume Production Overnight After QuakeA Million Simulations, One Verdict for US Economy: Debt Danger AheadTrump Media’s Business Doesn’t Matter

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

02 Apr, 2024 @ 14:15 by Yahoo! Finance

These stocks could move in very different directions over the long run.

Old Arcived News About Novavax Inc

  • Huge PowerShares ETF Rebalance Means Massive Buying for 4 Biotech Stocks.
  • Insider Trading Alert - PII, NVAX And NOG Traded By Insiders.
  • Novavax.
  • Novavax (NVAX) Is Today's Perilous Reversal Stock.
  • Novavax (NVAX) Is Weak On High Volume Today.
  • Novavax (NVAX) Marked As A Dead Cat Bounce Stock.
  • Novavax (NVAX) Showing Signs Of A Dead Cat Bounce Today.
  • Novavax (NVAX) Stock Plunges on Disappointing Q4 Results.
  • Novavax Falls as Respiratory Vaccine Results Don't Impress.
  • NOVAVAX INC Files SEC form 10-Q, Quarterly Report.
  • NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits.
  • NOVAVAX INC Financials.
  • Novavax Inc. Enters a New Phase.
  • Novavax Initiates Global Pivotal Phase 3 Trial of the RSV F Vaccine to Protect Infants via Maternal Immunization. [GlobeNewswire] - GAITHERSBURG, Md., Dec. 03, 2015-- Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today ...
  • Novavax reports 3Q loss.
  • Novavax Reports Third Quarter 2015 Financial Results -. [at noodls] - Novavax Reports Third Quarter 2015 Financial Results -
  • Novavax Surges on Vaccine Success Against Respiratory Disease.
  • Novavax to Make Multiple Presentations at RSV Vaccines for the World. [GlobeNewswire] - GAITHERSBURG, Md., Nov. 16, 2015-- Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today ...
  • Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference. [GlobeNewswire] - GAITHERSBURG, Md., Nov. 24, 2015-- Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today ...
  • Novavax to Present at the Stifel 2015 Healthcare Conference. [GlobeNewswire] - GAITHERSBURG, Md., Nov. 10, 2015-- Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today ...
  • Novavax, Inc. – Value Analysis.
  • Novavax, Inc. breached its 50 day moving average in a Bullish Manner : November 25, 2015.
  • Novavax, Inc. Earnings Q3, 2015.
  • Q3 2015 Novavax Inc Earnings Release - Before Market Open.
  • Stock Market Video Analysis for Week Ending 12/5/14.
  • Stock To Watch: Novavax (NVAX) In Perilous Reversal.
  • What Do Hedge Funds Think of Novavax, Inc..
  • Why Novavax Inc Is Moving Higher Today.

Novavax Inc Short Company Overview:

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.